Table 1.
|
Clinician collected |
Self-collected |
||||||
---|---|---|---|---|---|---|---|---|
OR | p | 95% CI | ptrend | OR | p | 95% CI | ptrend | |
Any HPV |
1.2 |
0.4 |
0.77-1.8 |
0.01 |
1.0 |
0.9 |
0.68-1.6 |
0.03 |
Carcinogenic |
1.1 |
0.6 |
0.66-2.0 |
<0.001 |
1.4 |
0.1 |
0.90-2.3 |
0.004 |
Non-Carcinogenic |
1.1 |
0.7 |
0.69-1.8 |
0.8 |
0.73 |
0.2 |
0.46-1.2 |
0.7 |
alpha 1/8/10 |
1.4 |
0.6 |
0.44-4.5 |
0.5 |
1.9 |
0.2 |
0.74-4.7 |
0.8 |
alpha 5/6/7/9/11 |
0.94 |
0.8 |
0.59-4.5 |
0.003 |
1.1 |
0.6 |
0.74-1.7 |
0.01 |
alpha 3/4/15 | 1.1 | 0.8 | 0.64-1.8 | 0.4 | 0.79 | 0.3 | 0.51-1.2 | 0.7 |
Odds ratios (OR) with 95% confidence intervals (95%CI) were calculated as a measure of association of women not having been screened in the last 3 years (vs. the reference of those who had) with HPV detection; p value was included for reference. Age groups were modeled continuously to assess the age trend (ptrend).